LobbyingRoche Diagnostics lobbying by quarter
Roche Diagnostics's latest lobbying report covers Q2 2026, at $70K. The four quarters Q4 2025–Q3 2026 total $210K. Its first report covers Q1 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Roche Diagnostics
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $210K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q1 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2022 | $62K | 1 |
| Q2 2022 | $62K | 1 |
| Q3 2022 | $78K | 1 |
| Q4 2022 | $178K | 6 |
| Q1 2023 | $124K | 5 |
| Q2 2023 | $114K | 5 |
| Q3 2023 | $104K | 5 |
| Q4 2023 | $128K | 4 |
| Q1 2024 | $98.5K | 4 |
| Q2 2024 | $60K | 3 |
| Q3 2024 | $70K | 4 |
| Q4 2024 | $115K | 5 |
| Q1 2025 | $85K | 4 |
| Q2 2025 | $85K | 4 |
| Q3 2025 | $85K | 4 |
| Q4 2025 | $70K | 4 |
| Q1 2026 | $70K | 3 |
| Q2 2026 | $70K | 3 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$983.7K · 39 reports
- Medicare and Medicaid$382.5K · 17 reports
- Foreign relations$197.2K · 7 reports
- Medical research and clinical labs$42.5K · 3 reports
- Trade$40K · 2 reports
- Budget and appropriations$12.5K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES39 reports
- SENATE33 reports
- State, Dept of (DOS)5 reports
- U.S. Agency for International Development (USAID)5 reports
- Centers For Medicare and Medicaid Services (CMS)3 reports
- Health & Human Services, Dept of (HHS)2 reports
- Administration for Children & Families (ACF)1 reports
- White House Office1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Rosewood Global Advisors | $518.5K | 9 quarters |
| DS2 Group | $440K | 15 quarters |
| Hooper, Lundy & Bookman, P.C. | $320K | 9 quarters |
| The McManus Group | $290K | 8 quarters |
| Manatt, Phelps, and Phillips | $60K | 5 quarters |
| MR. Richard Goodstein | $30K | 1 quarters |
| McDermott+ | $0 | 4 quarters |
| M.J. Simon & Company | $0 | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| DONN SALVOSA | 94; Staff Asst., Congressman Cliff Stearns; 95-2000; Staff Aide & Leg Clerk, House Energy and Commerce | Q2 2026 |
| NICHOLAS WILLIAM BATH jr | Health Policy Director of the U.S. Senate Committee on Health, Education, Labor and Pensions | Q3 2025 |
| LISA LAYMAN | SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996) | Q4 2024 |
| RACHEL STAUFFER | 2013-2015: Health Policy Director, Rep. Diana DeGette; 2008-2011: Legislative Assistant, Senior Legislative Assistant, Rep. John Tierney | Q4 2022 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | M.J. Simon & Company | Under $5,000 |
| 07/20for Q2 | The McManus Group | $40K |
| 07/02for Q2 | DS2 Group | $30K |
| 04/20for Q1 | The McManus Group | $40K |
| 04/20for Q1 | M.J. Simon & Company | Under $5,000 |
| 04/02for Q1 | DS2 Group | $30K |
| 01/20for Q4 2025 | M.J. Simon & Company | Under $5,000 |
| 01/20for Q4 2025 | The McManus Group | $40K |
| 01/20for Q4 2025 | Manatt, Phelps, and Phillips | Under $5,000 |
| 01/03for Q4 2025 | DS2 Group | $30K |
| 25/10/20for Q3 2025 | M.J. Simon & Company | Under $5,000 |
| 25/10/20for Q3 2025 | The McManus Group | $40K |
| 25/10/16for Q3 2025 | Manatt, Phelps, and Phillips | $15K |
| 25/10/01for Q3 2025 | DS2 Group | $30K |
| 25/08/05for Q2 2025 | M.J. Simon & Company | Under $5,000 |
| 25/07/21for Q2 2025 | The McManus Group | $40K |
| 25/07/17for Q2 2025 | Manatt, Phelps, and Phillips | $15K |
| 25/07/07for Q2 2025 | DS2 Group | $30K |
| 25/05/06for Q1 2025 | Manatt, Phelps, and Phillips | $15K |
| 25/04/21for Q1 2025 | The McManus Group | $40K |